__timestamp | Amphastar Pharmaceuticals, Inc. | Catalyst Pharmaceuticals, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 28427000 | 10117774 |
Thursday, January 1, 2015 | 37065000 | 11801342 |
Friday, January 1, 2016 | 41199000 | 11369941 |
Sunday, January 1, 2017 | 43415000 | 11375237 |
Monday, January 1, 2018 | 57564000 | 19919204 |
Tuesday, January 1, 2019 | 68853000 | 18842752 |
Wednesday, January 1, 2020 | 67229000 | 16496715 |
Friday, January 1, 2021 | 60932000 | 16936000 |
Saturday, January 1, 2022 | 74771000 | 19789000 |
Sunday, January 1, 2023 | 73741000 | 93150000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Amphastar Pharmaceuticals, Inc. and Catalyst Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Amphastar's R&D expenses grew by approximately 160%, peaking in 2022. This steady increase underscores their commitment to expanding their product pipeline. In contrast, Catalyst Pharmaceuticals saw a dramatic surge in 2023, with R&D spending skyrocketing by over 370% compared to 2014. This leap suggests a strategic pivot towards aggressive innovation. While Amphastar's consistent growth reflects a stable approach, Catalyst's recent spike indicates a bold move to capture market share. As these companies navigate the ever-evolving pharmaceutical landscape, their R&D investments will be crucial in determining their future success.
Research and Development Expenses Breakdown: AstraZeneca PLC vs Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Amphastar Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. or Catalyst Pharmaceuticals, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: BeiGene, Ltd. vs Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Summit Therapeutics Inc. vs Catalyst Pharmaceuticals, Inc.
Corcept Therapeutics Incorporated or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
ADMA Biologics, Inc. vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
Research and Development Investment: Catalyst Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Catalyst Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending